Surfactant Protein D (SP-D), a marker for interstitial lung diseases (ILDs) and ARDS (23), exhibited a significant increase of 2.5-fold in mice administered with 0.15 mL/kg OA. Here, SFTPD is linked to interstitial lung disease.